UPDATED Apr 12, 2024
High return on equity, past performance and sound balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
AMPY | US$7.09 | 3.4% | -6.1% | US$284.0m | US$9.25 | PE0.7x | E-133.0% | 0% | ||
SDPI | US$1.10 | -1.6% | 10.1% | US$34.3m | n/a | PE4.5x | n/a | n/a | ||
ORL | ₪1.14 | -4.0% | 17.1% | ₪3.6b | ₪1.64 | PE2.3x | n/a | 20.3% | ||
TATN | ₽409.90 | 0% | -26.5% | ₽915.4b | n/a | PE4.6x | n/a | 9.5% | ||
CDEV | ₪102.50 | 1.9% | 8.0% | ₪659.1m | n/a | PE8x | n/a | 10.6% |